Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Osteopetrosis with syndactyly; a morphological variant of Albers-Schönberg's disease.

TRUSWELL AS.

J Bone Joint Surg Br. 1958 May;40-B(2):209-18. No abstract available.

PMID:
13539104
2.

Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.

Kusu N, Laurikkala J, Imanishi M, Usui H, Konishi M, Miyake A, Thesleff I, Itoh N.

J Biol Chem. 2003 Jun 27;278(26):24113-7. Epub 2003 Apr 17.

3.

Differentiation of murine preosteoblastic KS483 cells depends on autocrine bone morphogenetic protein signaling during all phases of osteoblast formation.

van der Horst G, van Bezooijen RL, Deckers MM, Hoogendam J, Visser A, Löwik CW, Karperien M.

Bone. 2002 Dec;31(6):661-9.

PMID:
12531559
4.

Structural basis of BMP signalling inhibition by the cystine knot protein Noggin.

Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Izpisua Belmonte JC, Choe S.

Nature. 2002 Dec 12;420(6916):636-42.

PMID:
12478285
5.

Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms.

Balemans W, Foernzler D, Parsons C, Ebeling M, Thompson A, Reid DM, Lindpaintner K, Ralston SH, Van Hul W.

Bone. 2002 Oct;31(4):515-9.

PMID:
12398949
6.

Do bone cells behave like a neuronal network?

Turner CH, Robling AG, Duncan RL, Burr DB.

Calcif Tissue Int. 2002 Jun;70(6):435-42. Epub 2002 Mar 27. Review.

PMID:
12149636
7.

Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis.

Tsumaki N, Nakase T, Miyaji T, Kakiuchi M, Kimura T, Ochi T, Yoshikawa H.

J Bone Miner Res. 2002 May;17(5):898-906.

8.

Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.

Deckers MM, van Bezooijen RL, van der Horst G, Hoogendam J, van Der Bent C, Papapoulos SE, Löwik CW.

Endocrinology. 2002 Apr;143(4):1545-53.

PMID:
11897714
9.

Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.

Hart PJ, Deep S, Taylor AB, Shu Z, Hinck CS, Hinck AP.

Nat Struct Biol. 2002 Mar;9(3):203-8.

PMID:
11850637
10.

A role for the BMP antagonist chordin in endochondral ossification.

Zhang D, Ferguson CM, O'Keefe RJ, Puzas JE, Rosier RN, Reynolds PR.

J Bone Miner Res. 2002 Feb;17(2):293-300.

11.

Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures.

Gaddy-Kurten D, Coker JK, Abe E, Jilka RL, Manolagas SC.

Endocrinology. 2002 Jan;143(1):74-83.

PMID:
11751595
12.

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C, Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L, Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L, FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B, McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ, Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML.

Am J Hum Genet. 2002 Jan;70(1):11-9. Epub 2001 Dec 3.

13.

LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Gong Y, Slee RB, Fukai N, Rawadi G, Roman-Roman S, Reginato AM, Wang H, Cundy T, Glorieux FH, Lev D, Zacharin M, Oexle K, Marcelino J, Suwairi W, Heeger S, Sabatakos G, Apte S, Adkins WN, Allgrove J, Arslan-Kirchner M, Batch JA, Beighton P, Black GC, Boles RG, Boon LM, Borrone C, Brunner HG, Carle GF, Dallapiccola B, De Paepe A, Floege B, Halfhide ML, Hall B, Hennekam RC, Hirose T, Jans A, Jüppner H, Kim CA, Keppler-Noreuil K, Kohlschuetter A, LaCombe D, Lambert M, Lemyre E, Letteboer T, Peltonen L, Ramesar RS, Romanengo M, Somer H, Steichen-Gersdorf E, Steinmann B, Sullivan B, Superti-Furga A, Swoboda W, van den Boogaard MJ, Van Hul W, Vikkula M, Votruba M, Zabel B, Garcia T, Baron R, Olsen BR, Warman ML; Osteoporosis-Pseudoglioma Syndrome Collaborative Group..

Cell. 2001 Nov 16;107(4):513-23.

14.

Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice.

Akhter MP, Cullen DM, Gong G, Recker RR.

Bone. 2001 Aug;29(2):121-5.

PMID:
11502472
15.

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).

Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W.

Hum Mol Genet. 2001 Mar 1;10(5):537-43.

PMID:
11181578
16.

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Brunkow ME, Gardner JC, Van Ness J, Paeper BW, Kovacevich BR, Proll S, Skonier JE, Zhao L, Sabo PJ, Fu Y, Alisch RS, Gillett L, Colbert T, Tacconi P, Galas D, Hamersma H, Beighton P, Mulligan J.

Am J Hum Genet. 2001 Mar;68(3):577-89. Epub 2001 Feb 9.

17.

Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.

Pereira RC, Economides AN, Canalis E.

Endocrinology. 2000 Dec;141(12):4558-63.

PMID:
11108268
18.

Overexpression of DAN causes a growth suppression in p53-deficient SAOS-2 cells.

Hanaoka E, Ozaki T, Nakamura Y, Moriya H, Nakagawara A, Sakiyama S.

Biochem Biophys Res Commun. 2000 Nov 11;278(1):20-6.

PMID:
11071849
19.

Crystal structure of the BMP-2-BRIA ectodomain complex.

Kirsch T, Sebald W, Dreyer MK.

Nat Struct Biol. 2000 Jun;7(6):492-6.

PMID:
10881198
20.

Molecular events caused by mechanical stress in bone.

Nomura S, Takano-Yamamoto T.

Matrix Biol. 2000 May;19(2):91-6. Review.

PMID:
10842092

Supplemental Content

Support Center